Gilbert S. Omenn, Director at Esperion Therapeutics, Inc. (ESPR), bought 1,000 shares at $42.26 ($42K) on 2017-03-21, disclosed to the SEC on 2017-03-22.
Open-market purchase of $42k ESPR by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| AMST | BUY | 2020-09-29 | $100K | — | Filing → |
| GALT | BUY | 2019-06-03 | $159K | — | Filing → |
| GALT | SELL | 2018-09-11 | $117K | — | Filing → |